Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.51 |
| ▸ | HPGD | P15428 | 2/20 | 0.51 |
| ▸ | EPHX1 | P07099 | 3/20 | 0.47 |
| ▸ | ERCC5 | P28715 | 1/20 | 0.44 |
| ▸ | FEN1 | P39748 | 1/20 | 0.44 |
| ▸ | PARP1 | P09874 | 1/20 | 0.44 |
| ▸ | EPHX2 | P34913 | 4/20 | 0.42 |
| ▸ | SCN5A | Q14524 | 3/20 | 0.42 |
| ▸ | SCN9A | Q15858 | 3/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tetrabuthylammonium SCHEMBL8765761 | 0.95 | ALDH1A1 (0.47) | ALDH1A1HPGDEPHX1ERCC5FEN1 | |
| Tetrabuthylammonium SCHEMBL10603643 | 0.93 | ALDH1A1 (0.46) | ALDH1A1HPGDEPHX1ERCC5FEN1 | |
| Tributylmethylammonium SCHEMBL9790212 | 0.90 | ALDH1A1 (0.50) | ALDH1A1HPGDEPHX1ERCC5FEN1 | |
| Tetrabuthylammonium SCHEMBL107181 | 0.89 | SMN1; SMN2 (0.47) | — | |
| Cetrimonium SCHEMBL11203681 | 0.87 | ALDH1A1 (0.48) | ALDH1A1HPGDEPHX1ERCC5FEN1 | |
| Tetrabuthylammonium SCHEMBL512903 | 0.87 | ALDH1A1 (0.52) | ALDH1A1HPGDEPHX1ERCC5FEN1 | |
| Tetrabuthylammonium SCHEMBL107183 | 0.84 | PLA2G4B (0.45) | — | |
| Tetrabuthylammonium SCHEMBL11373850 | 0.84 | PLA2G4B (0.45) | — | |
| Isophthalic Acid SCHEMBL29465122 | 0.83 | SMN1; SMN2 (0.45) | ALDH1A1HPGD | |
| Tetrabuthylammonium SCHEMBL3188178 | 0.81 | CA1 (0.60) | ALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 719 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1534759-B1 | MACROMER FORMING CATALYSTS | JOHNSON & JOHNSON VISION CARE (US) | 2009-09-09 | — | — | EP | claimed |
| US-20060004119-A1 | Macromer forming catalysts | JOHNSON & JOHNSON VISION CARE, INC. | 2006-01-05 | — | — | US | claimed |
| CN-1675252-A | Macromer forming catalysts | JOHNSON & JOHNSON VISION CARE (US) | 2005-09-28 | — | — | CN | claimed |
| EP-1534759-A1 | MACROMER FORMING CATALYSTS | Johnson & Johnson Vision Care, Inc. (US) | 2005-06-01 | — | — | EP | claimed |
| US-20040002556-A1 | Macromer forming catalysts | JOHNSON & JOHNSON VISION CARE, INC. | 2004-01-01 | — | — | US | claimed |
| WO-2004000888-A1 | MACROMER FORMING CATALYSTS | JOHNSON & JOHNSON VISION CARE, INC. (US) | 2003-12-31 | — | — | WO | claimed |
| US-4736003-A | HIGH MOLECULAR WEIGHT ACRYLIC POLYMERS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1988-04-05 | — | — | US | claimed |
| US-4588795-A | ADDITION POLYMERIZATION OF LIVING POLYMERS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1986-05-13 | — | — | US | claimed |
| US-12636247-B2 | Cosmetic | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2026-05-26 | — | — | US | disclosed |
| EP-4154970-B1 | USE OF A DIBLOCK COPOLYMER AS EMULSIFIER | SHINETSU CHEMICAL CO (JP) | 2026-04-08 | — | — | EP | disclosed |
| US-12286543-B2 | Image forming method | Konica Minolta, Inc. (JP) | 2025-04-29 | — | — | US | disclosed |
| CN-119781244-A | Photosensitive composition for color filter, image display device, and solid-state imaging element | 爱天思株式会社 | 2025-04-08 | — | — | CN | disclosed |
| CN-114341215-B | Curable composition | 株式会社日本触媒 | 2024-12-27 | — | — | CN | disclosed |
| US-12116492-B2 | Non-pigmented dispersant composition | BYK-CHEMIE GMBH (DE) | 2024-10-15 | — | — | US | disclosed |
| EP-0248596-A2 | Durable epoxy (meth) acrylic polymer with oxirane-containing terminal groups and preparation | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1987-12-09 | — | — | EP | disclosed |
| WO-1987007265-A1 | ACYLATION AND SULFONATION OF SILYLKETENE ACETALS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1987-12-03 | — | — | WO | disclosed |
| EP-0244953-A1 | Enhanced livingness of polymerization using silylated oxyanions | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1987-11-11 | — | — | EP | disclosed |
| EP-0243120-A2 | Tough flexible polymer blends | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1987-10-28 | — | — | EP | disclosed |
| EP-0218436-A2 | Acrylic pigment dispersant made by group transfer polymerization | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1987-04-15 | — | — | EP | disclosed |
| US-4656226-A | BLOCK POLYMERS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1987-04-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12636247-B2 | Cosmetic | MSR1, TLR3, LOXL1 | ALDH1A1 459/4885HPGD 1753/4885EPHX1 1113/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.